150 related articles for article (PubMed ID: 10788682)
1. Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects.
De Ruysscher D; Vansteenkiste J
Radiother Oncol; 2000 Apr; 55(1):1-9. PubMed ID: 10788682
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
3. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
4. Combined platinum etoposide with radiation therapy in limited stage small cell lung cancer: an effective treatment strategy.
Turrisi AT
Lung Cancer; 1995 Jun; 12 Suppl 3():S41-51. PubMed ID: 7551955
[No Abstract] [Full Text] [Related]
5. Long term results of surgery and chemotherapy in small cell lung cancer.
Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F
Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145
[TBL] [Abstract][Full Text] [Related]
6. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
7. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
De Ruysscher D; Pijls-Johannesma M; Bentzen SM; Minken A; Wanders R; Lutgens L; Hochstenbag M; Boersma L; Wouters B; Lammering G; Vansteenkiste J; Lambin P
J Clin Oncol; 2006 Mar; 24(7):1057-63. PubMed ID: 16505424
[TBL] [Abstract][Full Text] [Related]
8. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
9. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818
[TBL] [Abstract][Full Text] [Related]
10. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
[TBL] [Abstract][Full Text] [Related]
11. Combined chemoradiation therapy for limited-stage small-cell lung cancer.
Teng M; Choy H; Ettinger D
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):107-15. PubMed ID: 10550834
[TBL] [Abstract][Full Text] [Related]
12. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
13. Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival.
Watkins JM; Wahlquist AE; Zauls AJ; Shirai K; Garrett-Mayer E; Aguero EG; Silvestri GA; Sherman CA; Sharma AK
J Med Imaging Radiat Oncol; 2010 Oct; 54(5):483-9. PubMed ID: 20958948
[TBL] [Abstract][Full Text] [Related]
14. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P
Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
Kubota K; Nishiwaki Y; Sugiura T; Noda K; Mori K; Kawahara M; Negoro S; Watanabe K; Imamura F; Tamura T; Saijo N
Clin Cancer Res; 2005 Aug; 11(15):5534-8. PubMed ID: 16061870
[TBL] [Abstract][Full Text] [Related]
16. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775
[TBL] [Abstract][Full Text] [Related]
17. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer.
Quon H; Shepherd FA; Payne DG; Coy P; Murray N; Feld R; Pater J; Sadura A; Zee B
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):39-45. PubMed ID: 9989512
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
Schild SE; Bonner JA; Shanahan TG; Brooks BJ; Marks RS; Geyer SM; Hillman SL; Farr GH; Tazelaar HD; Krook JE; Geoffroy FJ; Salim M; Arusell RM; Mailliard JA; Schaefer PL; Jett JR
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):943-51. PubMed ID: 15234027
[TBL] [Abstract][Full Text] [Related]
20. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
Payne DG; Murray N; Warde P
Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
